<< Back To Home

WHAT'S NEW THIS TUESDAY: SIX ON NEGLECTED TROPICAL DISEASES

Sunday, 3rd of February 2013 Print
  • WHAT’S NEW THIS TUESDAY: SIX ON NEGLECTED TROPICAL DISEASES
  • NEGLECTED TROPICAL DISEASES – PROGRESS AND PRIORITIES 

From The Lancet editorial page,  26 January 2013 

This January marks the first anniversary of the London Declaration on Neglected Tropical Diseases—a coordinated effort by endemic countries, nongovernmental organisations, drug companies, and donors to improve the lives of more than a billion of the world’s poorest people by the end of the decade. A year on from the launch, the results look promising.

 

Pharmaceutical partners involved with the initiative have supplied 1·12 billion treatments, Oman became the first previously endemic country to verify the elimination of trachoma, and more than 40 countries have since developed long-term plans to tackle neglected tropical diseases. The progress achieved represents what can be done if a concerted international effort is made—eg, the strides towards the elimination of guinea worm and yaws. However, the fi ght is far from over. WHO reports that dengue is now the world’s fastest spreading tropical disease and “represents a pandemic threat”. 

WHO issued its first report on the burden of neglected tropical diseases in 2010—a roadmap for control, elimination, or eradication—including drug and vaccine development. In April, 2012, the Consultative Expert Working Group on Research and Development (R&D) recommended a framework for sustainable financing and coordination implemented through a legally binding convention. However, this week WHO’s Executive Board has been asked to endorse a less ambitious plan by member states for a more vaguely defined WHO Observatory on Global Health R&D, which is weak on concrete action despite international consensus that the current R&D model needs revision. The 2013 World Health Assembly should be more ambitious and put back on the agenda the proposal for new global rules to secure sustained fi nancing mechanisms for essential health R&D. The future elimination and eradication of neglected tropical diseases depends on it. 􀂄 The Lancet

 

  • NEGLECTED TROPICAL DISEASES: SURVEY AND GEOMETRY OF RANDOMISED EVIDENCE

“There is considerable variation in the amount of evidence from randomised controlled trials for each of the 16 major neglected tropical diseases.”

 

BMJ. 2012 Oct 22

 

Kappagoda SIoannidis JP.

Source

Center for Primary Care and Outcomes Research and Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Abstract below; full text is at http://www.bmj.com/content/345/bmj.e6512?view=long&pmid=23089149

OBJECTIVE:

To assess the quantity and distribution of evidence from randomised controlled trials for the treatment of the major neglected tropical diseases and to identify gaps in the evidence with network analysis.

DESIGN:

Systematic review and network analysis.

DATA SOURCES:

Cochrane Central Register of Controlled Trials and PubMed from inception to 31 August 2011.

STUDY SELECTION:

Randomised controlled trials that examined treatment of 16 neglected tropical diseases or complications thereof published in English, French, Spanish, Portuguese, German, or Dutch.

RESULTS:

We identified 971 eligible randomised trials. Leishmaniasis (184 trials, 23,039 participants) and geohelminth infections; 160 trials, 46,887 participants) were the most studied, while dracunculiasis (nine trials, 798 participants) and Buruli ulcer (five trials, 337 participants) were least studied. Relative to its global burden of disease, lymphatic filariasis had the fewest trials and participants. Only 11% of trials were industry funded. Either a single trial or trials with fewer than 100 participants comprised the randomised evidence for first or second line treatments for Buruli ulcer, human African trypanosomiasis, American trypanosomiasis, cysticercosis, rabies, echinococcosis, New World cutaneous leishmaniasis, and each of the foodborne trematode infections. Among the 10 disease categories with more than 40 trials, five lacked sufficient head to head comparisons between first or second line treatments.

CONCLUSIONS:

There is considerable variation in the amount of evidence from randomised controlled trials for each of the 16 major neglected tropical diseases. Even in diseases with substantial evidence, such as leishmaniasis and geohelminth infections, some recommended treatments have limited supporting data and lack head to head comparisons.

  • NTD COLLECTION:

 

From the Public Library of Science

 

http://www.ploscollections.org/article/browseIssue.action?issue=info:doi/10.1371/issue.pcol.v08.i04

 

  • NTDs IN ETHIOPIA

 

The burden of Neglected Tropical Diseases in

Ethiopia, and opportunities for integrated control

and elimination

Kebede Deribe et al.

 

Abstract below; full text,

http://www.parasitesandvectors.com/content/pdf/1756-3305-5-240.pdf 

 

Background

Neglected tropical diseases (NTDs) are a group of chronic parasitic diseases and related

conditions that are the most common diseases among the 2·7 billion people globally living on

less than US$2 per day. In response to the growing challenge of NTDs, Ethiopia is preparing

to launch a NTD Master Plan. The purpose of this review is to underscore the burden of

NTDs in Ethiopia, highlight the state of current interventions, and suggest ways forward.

 

Results

This review indicates that NTDs are significant public health problems in Ethiopia. From the

analysis reported here, Ethiopia stands out for having the largest number of NTD cases

following Nigeria and the Democratic Republic of Congo. Ethiopia is estimated to have the

highest burden of trachoma, podoconiosis and cutaneous leishmaniasis in sub-Saharan Africa

(SSA), the second highest burden in terms of ascariasis, leprosy and visceral leishmaniasis,

and the third highest burden of hookworm. Infections such as schistosomiasis, trichuriasis,

lymphatic filariasis and rabies are also common. A third of Ethiopians are infected with

ascariasis, one quarter is infected with trichuriasis and one in eight Ethiopians lives with

hookworm or is infected with trachoma. However, despite these high burdens of infection,

the control of most NTDs in Ethiopia is in its infancy. In terms of NTD control achievements,

Ethiopia reached the leprosy elimination target of 1 case/10,000 population in 1999. No cases

of human African trypanosomiasis have been reported since 1984. Guinea worm eradication

is in its final phase. The Onchocerciasis Control Program has been making steady progress

since 2001. A national blindness survey was conducted in 2006 and the trachoma program

has kicked off in some regions. Lymphatic Filariasis, podoconiosis and rabies mapping are

underway.

 

Conclusion

Ethiopia bears a significant burden of NTDs compared to other SSA countries. To achieve

success in integrated control of NTDs, integrated mapping, rapid scale up of interventions

and operational research into co implementation of intervention packages will be crucial.

  • NEGLECTED TROPICAL  DISEASES OF THE MIDDLE EAST AND NORTH AFRICA: REVIEW OF THEIR PREVALENCE, DISTRIBUTION, AND OPPORTUNITIES FOR CONTROL.

Hotez PJSavioli LFenwick A.

Source

Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. hotez@bcm.edu

Abstract below; full text is at

http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0001475 

The neglected tropical diseases (NTDs) are highly endemic but patchily distributed among the 20 countries and almost 400 million people of the Middle East and North Africa (MENA) region, and disproportionately affect an estimated 65 million people living on less than US$2 per day. Egypt has the largest number of people living in poverty of any MENA nation, while Yemen has the highest prevalence of people living in poverty. These two nations stand out for having suffered the highest rates of many NTDs, including the soil-transmitted nematode infections, filarial infections, schistosomiasis, fascioliasis, leprosy, and trachoma, although they should be recognized for recent measures aimed at NTD control. Leishmaniasis, especially cutaneous leishmaniasis, is endemic in Syria, Iran, Iraq, Libya, Morocco, and elsewhere in the region. Both zoonotic (Leishmania major) and anthroponotic (Leishmania tropica) forms are endemic in MENA in rural arid regions and urban regions, respectively. Other endemic zoonotic NTDs include cystic echinococcosis, fascioliasis, and brucellosis. Dengue is endemic in Saudi Arabia, where Rift Valley fever and Alkhurma hemorrhagic fever have also emerged. Great strides have been made towards elimination of several endemic NTDs, including lymphatic filariasis in Egypt and Yemen; schistosomiasis in Iran, Morocco, and Oman; and trachoma in Morocco, Algeria, Iran, Libya, Oman, Saudi Arabia, Tunisia, and the United Arab Emirates. A particularly noteworthy achievement is the long battle waged against schistosomiasis in Egypt, where prevalence has been brought down by regular praziquantel treatment. Conflict and human and animal migrations are key social determinants in preventing the control or elimination of NTDs in the MENA, while local political will, strengthened international and intersectoral cooperative efforts for surveillance, mass drug administration, and vaccination are essential for elimination.

 

 

  • NEGLECTED TROPICAL DISEASES IN THE U.S. AND CHINA

 

EDITORIAL

Engaging a Rising China through Neglected Tropical Diseases

Peter J. Hotez

Best viewed, with maps and graphics, at http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0001599

* E-mail: hotez@bcm.edu

Affiliations: Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Houston, Texas, United States of America, National School of Tropical Medicine, Department of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, United States of America, James A. Baker III Institute for Public Policy, Rice University, Houston, Texas, United States of America 

  • ·Figures

Citation: Hotez PJ (2012) Engaging a Rising China through Neglected Tropical Diseases. PLoS Negl Trop Dis 6(11): e1599. doi:10.1371/journal.pntd.0001599

Published: November 29, 2012

Copyright: © 2012 Peter J. Hotez. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: The author received no funding for this work.

Competing interests: The author has declared that no competing interests exist.

* E-mail: hotez@bcm.edu

Peter Hotez, MD, PhD, FASTMH, FAAP, is Co-Editor-in-Chief of PLOS Neglected Tropical Diseases. He is Professor of Pediatrics and Molecular Virology & Microbiology, and Dean of the National School of Tropical Medicine, Baylor College of Medicine; Head of the Section of Pediatric Tropical Medicine and Texas Children's Hospital Endowed Chair of Tropical Pediatrics, Texas Children's Hospital; and Baker Institute Fellow in Disease and Poverty, Rice University. He is also President of the Sabin Vaccine Institute.

At the end of the day, there is no handbook for the evolving US–China relationship. But the stakes are much too high for us to fail.

—United States Secretary of State Hilary Clinton [1]

A 2012 joint survey of international relations scholars at universities in the United States and global policymakers in the US government revealed some sharp disagreements between these two groups with respect to the priority rankings of the top foreign policy problems facing the US in the next decade and beyond [2]. Whereas the academics prioritized global climate change and the collapse of the euro, the US policymakers highlighted international terrorism and the proliferation of weapons of mass destruction [2]. Both groups, however, were in agreement that the rising power of China represents the single most formidable problem facing the US [2]. Similar sentiments were echoed by US Secretary of State Hillary Clinton, who began a key November 2011 foreign policy document entitled “America's Pacific Century" with the following statement: “The future of politics will be decided in Asia, not Afghanistan or Iraq, and the United States will be right at the center of the action" [1]. Her statement also highlights China's special role in American foreign policy and the urgency for the US and China “to work together to ensure strong, sustained, and balanced future global growth" [1].

The global control and elimination of the world's neglected tropical diseases (NTDs) represent exciting and substantive opportunities to enhance and expand Sino–US relations. For the reasons highlighted below, the NTDs may also provide a useful framework for science diplomacy between the US and China in the coming decade.

Both China and the US share a historical legacy of NTDs, and the populations of both countries suffered greatly from NTDs during the 20th century. Up until the time of its liberation in 1949, China was often known as the “sick man of Asia," referring to the nation's pervasive poverty and disease, especially hookworm and other NTDs [3]. Schistosomiasis had an especially important impact on China's modern history and may have been a factor in thwarting a communist assault to take back Taiwan. During the Cold War, schistosomes were known as the “blood fluke that saved Formosa"—and the widespread presence of this infection in the Yangtze River valley prompted the mobilization of more than a million peasants to bury or remove schistosome-transmitting snails during the Great Leap Forward [4][5]. As late as the 1980s, a nationwide survey of almost 1.5 million people in all 30 provinces revealed that China had the world's largest number of cases of intestinal helminth infections, including more than 500 million cases of ascariasis and approximately 200 million cases each of trichuriasis and hookworm infection, in addition to almost 1 million cases of schistosomiasis [6]. Similarly, in the US during the first half of the 20th century, hookworm and other intestinal helminth infections, as well as typhoid fever and malaria, were highly endemic throughout the American South, where they hindered economic development and trapped people in poverty [7][8]. Outbreaks of yellow fever were also common [9].

Both China and the US made great strides in solving their own NTD problems. Over the past 50 years, China has made great strides in reducing the prevalence and intensity of some of its most important NTDs. For instance, through low-technology approaches directed at snail control and mass treatment (as well as overall improvements in sanitation and potable water), China reduced its schistosomiasis prevalence more than 90% from its initially documented level prior to the Great Leap Forward during the 1950s [10]. Similarly, through heroic national efforts at fortifying the salt with diethylcarbamazine citrate and mass drug administration in the decades following the Cultural Revolution, China became the first country to eliminate lymphatic filariasis, thereby paving the way for mass treatment efforts leading to global elimination [11]. Both China and the US made great progress in reducing the prevalence of hookworm and other intestinal helminth infections in the last half of the 20th century. While mass treatments of these infections undoubtedly had some role in these helminthic disease elimination efforts, the real contribution of large-scale mass chemotherapy relative to aggressive economic reforms remains unclear. Thus, China has achieved success in intestinal helminth control (primarily in eastern China) through programs of aggressive economic reform and urbanization during the last two decades [3], while the US reduced intestinal helminthiases and malaria through economic transformations of the American South, together with urbanization, beginning in the 1930s with the New Deal legislation [7][8][12].

The marginalized poor living in both China and the US still suffer from surprisingly high rates of NTDs. Despite enormous progress in NTD control, as a nation China still has some of the largest numbers of cases of selected NTDs anywhere in the world, although in many instances overall prevalence rates are low because of the enormous population. Shown in Table 1 is a list of the major NTDs in China and the US [13][15]. The tens of millions of cases of intestinal helminth infections that remain are mostly concentrated in China's poorest western provinces, especially in the southwestern provinces of Guizhou, Sichuan, and Yunnan [3][13] (Figure 1). Many of these helminth infections are hidden in remote rural and mountainous areas of these provinces [3]. Of interest is the observation that as economic development and some control measures have reduced intestinal helminth infections in eastern China, foodborne helminth infections such as clonorchiasis and echinococcosis may be emerging or on the rise [15]. Similarly, in the US there is a hidden burden of NTDs, especially in the poorest areas of Texas and the Gulf Coast [8][16][18] (Figure 2). While hookworm and other intestinal helminth infections are no longer as widespread in the US as they are in China, a unique largely urban set of NTDs has arisen in their place. They include hundreds of thousands of cases of Chagas disease, cysticercosis, toxocariasis, and trichomoniasis that disproportionately affect African-Americans and Hispanics living in poverty, as well as strongyloidiasis in Appalachia [8]. Thus, in both China and the US, NTDs remain as important health disparities. In the case of China, NTDs in the southwest remain an important challenge to its health system, while in the US, NTDs in the American South and elsewhere are still largely ignored and sadly conspicuous by their absence in any meaningful debate about US health care reform.

 

 

Figure 1. Poverty in China.

Average per capita income by province. Figure modified from Bloomberg Businessweek, May 8, 2000. http://www.businessweek.com/2000/00_19/b​3680013.htm, accessed January 19, 2012.

doi:10.1371/journal.pntd.0001599.g001

 

Figure 2. Poverty in the United States.

Percentage of people in poverty in the United States in 2009 and 2010 by state. Source: US Census Bureau, 2010 American Community Survey.

doi:10.1371/journal.pntd.0001599.g002

 

Table 1. Leading parasitic and other neglected tropical diseases in China and the US.

doi:10.1371/journal.pntd.0001599.t001

Both countries have tremendous capacity for lending their expertise and financial support for global NTD control. An important priority for both China and the US is to aggressively pursue national efforts to eliminate their respective NTDs, which currently represent glaring health disparities. In the US, legislation was introduced in the US Congress in 2011 to begin efforts for delineating the full extent of its neglected infections of poverty [19], while the Chinese Ministry of Health last conducted a full-fledged and extensive survey of its major parasitic infections in 2005. In parallel are some important outreach efforts to control and eliminate NTDs worldwide. Through its Neglected Tropical Diseases Program, the United States Agency for International Development (USAID) of the US Department of State has provided leadership and large-scale financial support for the deployment of rapid impact packages in order to integrate the control and/or elimination of seven NTDs, including ascariasis, trichuriasis, hookworm, schistosomiasis, lymphatic filariasis, onchocerciasis, and trachoma [20][21]. Current funding for this program may soon approach US$100 million annually in order to support more than a dozen national programs for NTD control and elimination in sub-Saharan Africa, Asia, and Latin America [20][21]. At the same time, according to the Asian Development Bank, China's trade with Africa has increased dramatically in recent years. By 2008 it had surpassed the US$100 billion mark [22], and is expected to exceed US$110 billion in 2011 [23]. Most of Africa's exports to China are based on mineral and oil resources, especially from Angola, Democratic Republic of Congo, South Africa, and Sudan [22]. China has provided aid and invested in infrastructure in sub-Saharan Africa since the 1960s, including a railroad that links Zambia with Tanzania [24]. Despite this enormous investment in African trade and an annual economic growth of 10% or more [25], China has not yet supported NTD control and elimination in Africa. This lack of investment in disease control and elimination for Africa is especially tragic given China's extraordinary expertise and track record in NTD control and elimination at home.

A new dialogue for NTD diplomacy. A joint Sino–US enterprise around NTDs and their control could be a powerful and winning combination. It could combine USAID's expertise in providing financial mechanisms and oversight in this area, as well as technical support through its public–private contractors, together with China's broad and deep expertise in parasite control linked to its history of investments in sub-Saharan Africa. Ultimately, given the current level of China's investment in Africa, it should not be onerous for China to match USAID's level of support for NTDs. Collaborating on NTD initiatives for Africa would also serve another important diplomatic purpose. It would get the two nations working together on an urgently needed peacetime project and mission, which would be both humanitarian and intellectually engaging. Cooperative efforts could include providing joint technical assistance to African health ministries in the areas of mass drug administration, integrated control and elimination through bundling of mass treatment approaches and concurrent operational research, and integrated vector management. Simultaneously, strengthening the capacity of Africa's research institutes and universities could also benefit from Sino–US scientific collaborations with African scientists. While a long-term approach to Africa's NTDs will also require economic development as it did in the US and China, a US–China NTD Initiative would nonetheless represent the very best of science diplomacy and is a project that could be initiated almost immediately.


References

1.   Clinton H (2011) America's Pacific century. Foreign Policy. November 2011. Available: http://www.foreignpolicy.com/articles/20​11/10/11/americas_pacific_century. Accessed 14 January 2012.

2.     Avey PC, Desch MC, Long JD, Maliniak D, Peterson S, et al.. (2012) The FP Survey: the ivory tower. Foreign Policy. January 2012. pp. 90–93.

3.     Hotez PJ (2002) China's hookworms. China Quarterly 172: 1029–1041. doi: 10.1017/S0009443902000608Find this article online

4.     Kernan FAJ (1959) The blood fluke that saved Formosa. Harper's Magazine (April) 45–47. Find this article online

5.     Horn JS (1969) Away with all pests: an English surgeon in People's China, 1954–1969, Monthly New York: Review Press. pp. 94–106.

6.     Yu SH, Xu LQ, Jiang ZX, Xu SH, Han JJ, et al. (1994) Special Report, Nationwide survey of human parasites in China. Southeast Asian Journal Trop Med Publ Health 25: 4–10. Find this article online

7.     Martin MG, Humphreys ME (2006) Social consequences of disease in the American South, 1900-World War II. South Med J 99: 862–864. doi: 10.1097/01.smj.0000231265.03256.1fFind this article online

8.     Hotez PJ (2008) Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis 2: e279 doi:10.1371/journal.pntd.0000279. .

9.     Crosby MC (2007) The American plague: the untold story of yellow fever, the epidemic that shaped our history. Berkley Trade, First Thus edition. 384 p.

10.  Utzinger J, Zhou XN, Chen MG, Bergquist R (2005) Conquering schistosomiasis in China: the long march. Acta Trop 96: 69–96. Find this article online

11.  Sudomo M, Chayabejara S, Duong S, Hernandez L, Wu WP, Bergquist R (2010) Elimination of lymphatic filariasis in Southeast Asia. Adv Parasitol 72: 205–233. Find this article online

12.  Humphreys M (2001) Malaria: poverty, race, and public health in the United States. Baltimore and London: Johns Hopkins University Press. 196 p.

13.  Ministry of Health China (2005) Report on the national survey of current situation of major human parasite diseases in China, National Institute of Parasitic Diseases.

14.  Hotez PJ, Ehrenberg JP (2010) Escalating the global fight against neglected tropical diseases through interventions in the Asia Pacific region. Adv Parasitol 72: 31–53. Find this article online

15.  Li T, He S, Zhao H, Zhao G, Zhu X-Q (2010) Major trends in human parasitic diseases in China. Trends Parasitol 26: 264–270. doi: 10.1016/j.pt.2010.02.007Find this article online

16.  Bern C, Montgomery SP (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49: e52–e54. doi: 10.1086/605091Find this article online

17.  Bern C, Kjos S, Yabsley MJ, Montgomery SP (2011) Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev 24: 655–681. doi: 10.1128/CMR.00005-11Find this article online

18.  Hotez PJ (2011) America's most distressed areas and their neglected infections: the United States Gulf Coast and the District of Columbia. PLoS Negl Trop Dis 5: e843 doi:10.1371/journal.pntd.0000843. .

19.  Hotez P, Stillwaggon E, McDonald M, Todman L, DiGrazia L (2010) National summit on neglected infections of poverty in the United States [conference summary]. Emerg Infect Dis 16: e1. Find this article online

20.  Linehan M, Hanson C, Weaver A, Baker A, Kabore A, et al. (2011) Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scale. Am J Trop Med Hyg 84: 5–14. doi: 10.4269/ajtmh.2011.10-0411Find this article online

21.  USAID (n.d.) USAID Neglected Tropical Disease Program. Available: http://www.neglecteddiseases.gov/. Accessed 15 January 2012.

22.  Sponsor Wire (2011) New AfDB study takes in-depth look at China-Africa partnership. September 20, 2011. Available: http://allafrica.com/stories/20110920136​9.html. Accessed 14 January 2012.

23.  Cossou E (2011) China-Africa trade set to keep on booming in 2011. BBC News. January 2, 2011. Available: http://www.bbc.co.uk/news/business-12098​204. Accessed 14 January 2012.

24.  BBC News (2007) China in Africa: developing ties. BBC News. November 26, 2007. Available: http://news.bbc.co.uk/2/hi/africa/708677​7.stm. Accessed 12 February 2012.

25.  Ewing K (2011) Unrest rattles China's Africa policy. Asia Times. May 2, 2011. http://atimes.com/atimes/China/MC02Ad02.​html. Accessed 14 January 2012. 



-- 
To subscribe or unsubscribe from these Child Survival Updates, pls contact kidsurvival@gmail.com. If you unsubscribe, indicate from which E mail address you are receving these updates.
 
When subscribing, write from your most permanent E-mail address, not always that of your current employer.
 
Do not subscribe on behalf of friends or colleagues; forward updates to them for their decision.

Those wishing to read only malaria updates should subscribe at
kidsurvivalmalaria@gmail.com
 

Those wishing to read only vaccination updates should subscribe at kidsurvivalvaccination@gmail.com
 
READER COMMENTS
  
If you have a comment you want posted, send to rdavis@africamail.com
WEBPAGE
 
These updates are also available at www.childsurvival.net  

41137659